vTv Therapeutics

VTVTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$139.319 M

$35.37 +2.20%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$27.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#286Nervgen PharmaNGEN$140.6M
#287Organigram GlobalOGI$139.4M
#288vTv TherapeuticsVTVT$139.3M
#289Unicycive TherapeuticsUNCY$138.9M
#290Connect BiopharmaCNTB$138.8M

Where these numbers come from

Share counts and financials for vTv Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.